RU-33965

N/A

Report date: 2022/02/11 15:31:35
NME

Base Information

Drug NameRU-33965
Drug Alias NameRU-33965
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA-A receptor; benzodiazepine site agonists
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsCognition DisordersAmnesiaAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsCognition DisordersAmnesiaAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A